J&J’s CSO to retire by the end of 2021

Dr. Paul Stoffels, who serves as Johnson & Johnson’s chief scientific officer, will end his tenure on December 31.

Stoffels, who is also vice-chairman of J&J’s executive committee, was responsible for reinvigorating J&J’s Janssen pharmaceutical pipeline and was instrumental in developing a COVID-19 vaccine.

The company’s CEO and executive chairman, Alex Gorsky, is also retiring from the company, effective January 3, 2022.

Dr. Paul Stoffels

Stoffels, a Belgian, intends to spend more time with his family in Europe.

Earlier in his career, Stoffels focused on tropical-disease research and antiviral drugs.

He co-founded the antiviral firm Tibotec-Virco, which Janssen acquired in 2002, paving the way to the company’s focus on HIV drugs.

Stoffels also had a passion for tackling tuberculosis and Ebola and pushed Janssen to develop treatments for them.

In 2020, St…

Read more
  • 0